Latest Articles
Emmy Nominee Dies of Endometrial Cancer: Jackie Burch Was 74 - PopCulture.com
Emmy Nominee Dies of Endometrial Cancer: Jackie Burch Was 74 PopCulture.com
Published: Oct. 20, 2025, 4:32 a.m.
Prime members can get a Kindle Paperwhite essentials bundle for $70 off - Mashable
Prime members can get a Kindle Paperwhite essentials bundle for $70 off Mashable
Published: Oct. 19, 2025, 10 p.m.
Cancer-linked chemical found in top European baby pacifier brands, including some sold in Israel - Ynetnews
Cancer-linked chemical found in top European baby pacifier brands, including some sold in Israel Ynetnews
Published: Oct. 19, 2025, 9:17 p.m.
Tecentriq Plus Chemo Shows Comparable Survival in Endometrial Cancer - CUREtoday.com
Tecentriq Plus Chemo Shows Comparable Survival in Endometrial Cancer CUREtoday.com
Published: Oct. 19, 2025, 6:39 p.m.
Giorgio Bogani: New Insights into POLE-Mutated Endometrial Cancer with Nodal Involvement - Oncodaily
Giorgio Bogani: New Insights into POLE-Mutated Endometrial Cancer with Nodal Involvement Oncodaily
Published: Oct. 18, 2025, 10:08 p.m.
Minister Apologizes for Endometriosis Treatment Delays and Introduces New Framework - Emegypt
Minister Apologizes for Endometriosis Treatment Delays and Introduces New Framework Emegypt
Published: Oct. 18, 2025, 9:47 p.m.
HSE Chief Bernard Gloster Announces New Endometriosis Plan to Enhance Surgical Care Access - Emegypt
HSE Chief Bernard Gloster Announces New Endometriosis Plan to Enhance Surgical Care Access Emegypt
Published: Oct. 18, 2025, 8:37 p.m.
Endometriosis framework launched 18 months late but promises major improvements in women’s care - Irish Examiner
Endometriosis framework launched 18 months late but promises major improvements in women’s care Irish Examiner
Published: Oct. 18, 2025, 3 p.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti - PharmiWeb.com
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti PharmiWeb.com
Published: Oct. 18, 2025, 1:03 p.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - Lelezard
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Lelezard
Published: Oct. 18, 2025, 12:47 p.m.
Link copied to clipboard!